← All tickers

Is CERS Worth Buying in 2026?

Cerus Corp

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-08-23

Here’s whether Cerus Corp (CERS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.28% over 10 days); strong 1-year return of +134.2%. Concerns: below the 50-day MA (medium-term momentum negative); RSI 77 — overbought, elevated pullback risk. Currently 19.0% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

CERS is holding above its long-term 200-day MA ($2.31) but has slipped below the 50-day MA ($2.81), pointing to short-term weakness in an otherwise intact trend. With an RSI of 77.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +134.2% compares to +20.5% for SPY (beat the market by 113.7%).

$10,000 invested 1 year ago → $23,417 today
vs. S&P 500 (SPY) — same period beat market by 113.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($2.31)
✗Above 50-day MA ($2.81)
!RSI(14) neutral zone (30–70) — currently 77.0
✓Positive return (+134.2%)
!Within 10% of period high (−19.0%)
Period Range $2.81
$1.15 $3.47
RSI (14) 77.0
0 · OversoldOverbought · 100

Key Metrics

Price$2.81
Period Return+134.2%
Period High$3.47
Period Low$1.15
Drawdown−19.0%
MA-50$2.81
MA-200$2.31
RSI (14)77.0
Avg Volume (30d)2.8M
vs. SPYbeat by 113.7%
Return Rank#91 of 999

Trade CERS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers